Approval · Notice of Compliance 14725 · 2013
KADCYLA: Notice of Compliance 14725
Issued September 11, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14725
- Date
- September 11, 2013
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KADCYLA | 02412365 | Marketed |
Medicinal ingredients
- TRASTUZUMAB EMTANSINE 20 MG per ML